SMTL ID : 7m8i.1

Human CYP11B2 and human adrenodoxin in complex with fadrozole

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.94 Å

Oligo State

homo-hexamer

Ligands

6 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)

FES.1: 13 residues within 4Å: Chain A: L.31, G.45, C.47, E.48, G.49, T.50, L.51, A.52, C.53, S.54, C.56, L.91, C.93 4 PLIP interactions: 4 interactions with chain A, Metal complexes: A:C.47, A:C.53, A:C.56, A:C.93 FES.4: 12 residues within 4Å: Chain B: L.31, G.45, C.47, G.49, T.50, L.51, A.52, C.53, S.54, C.56, L.91, C.93 3 PLIP interactions: 3 interactions with chain B, Metal complexes: B:C.47, B:C.53, B:C.56 FES.7: 12 residues within 4Å: Chain C: L.31, G.45, C.47, G.49, T.50, L.51, A.52, C.53, T.55, C.56, L.91, C.93 4 PLIP interactions: 4 interactions with chain C, Metal complexes: C:C.47, C:C.53, C:C.56, C:C.93 FES.10: 13 residues within 4Å: Chain D: L.31, G.45, C.47, E.48, G.49, T.50, L.51, A.52, C.53, S.54, C.56, L.91, C.93 4 PLIP interactions: 4 interactions with chain D, Metal complexes: D:C.47, D:C.53, D:C.56, D:C.93 FES.13: 12 residues within 4Å: Chain E: L.31, G.45, C.47, G.49, T.50, L.51, A.52, C.53, S.54, C.56, L.91, C.93 3 PLIP interactions: 3 interactions with chain E, Metal complexes: E:C.47, E:C.53, E:C.56 FES.16: 12 residues within 4Å: Chain F: L.31, G.45, C.47, G.49, T.50, L.51, A.52, C.53, T.55, C.56, L.91, C.93 4 PLIP interactions: 4 interactions with chain F, Metal complexes: F:C.47, F:C.53, F:C.56, F:C.93

6 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.2: 32 residues within 4Å: Chain A: R.212, V.231, F.232, W.239, R.243, L.306, E.412, L.413, G.416, S.417, T.420, T.421, P.424, L.475, V.480, G.481, F.483, L.484, R.486, P.544, F.545, G.546, F.547, R.550, Q.551, C.552, L.553, G.554, L.557, A.558, M.562 Ligands: 0T3.3 19 PLIP interactions: 19 interactions with chain A, Hydrophobic interactions: A:V.231, A:F.232, A:L.413, A:P.424, A:L.475, A:V.480, A:L.484, A:F.545, A:L.557, A:A.558 Hydrogen bonds: A:W.239, A:F.547, A:F.547 Salt bridges: A:R.212, A:R.212, A:R.243, A:R.486, A:R.550 Metal complexes: A:C.552 HEM.5: 33 residues within 4Å: Chain B: R.212, V.231, F.232, W.239, R.243, L.306, E.412, L.413, G.416, S.417, T.420, T.421, P.424, L.475, V.480, G.481, F.483, L.484, R.486, P.544, F.545, G.546, F.547, M.549, R.550, Q.551, C.552, L.553, G.554, L.557, A.558, M.562 Ligands: 0T3.6 19 PLIP interactions: 19 interactions with chain B, Hydrophobic interactions: B:V.231, B:F.232, B:L.413, B:P.424, B:L.475, B:V.480, B:L.484, B:F.545, B:L.557, B:A.558 Hydrogen bonds: B:W.239, B:F.547, B:F.547 Salt bridges: B:R.212, B:R.212, B:R.243, B:R.486, B:R.550 Metal complexes: B:C.552 HEM.8: 33 residues within 4Å: Chain C: R.212, V.231, F.232, W.239, R.243, L.306, E.412, L.413, G.416, S.417, T.420, T.421, P.424, L.475, V.480, G.481, F.483, L.484, E.485, R.486, P.544, F.545, G.546, F.547, R.550, Q.551, C.552, L.553, G.554, L.557, A.558, M.562 Ligands: 0T3.9 18 PLIP interactions: 18 interactions with chain C, Hydrophobic interactions: C:V.231, C:F.232, C:L.413, C:P.424, C:L.484, C:F.545, C:L.553, C:L.557, C:A.558 Hydrogen bonds: C:W.239, C:F.547, C:F.547 Salt bridges: C:R.212, C:R.212, C:R.243, C:R.486, C:R.550 Metal complexes: C:C.552 HEM.11: 32 residues within 4Å: Chain D: R.212, V.231, F.232, W.239, R.243, L.306, E.412, L.413, G.416, S.417, T.420, T.421, P.424, L.475, V.480, G.481, F.483, L.484, R.486, P.544, F.545, G.546, F.547, R.550, Q.551, C.552, L.553, G.554, L.557, A.558, M.562 Ligands: 0T3.12 19 PLIP interactions: 19 interactions with chain D, Hydrophobic interactions: D:V.231, D:F.232, D:L.413, D:P.424, D:L.475, D:V.480, D:L.484, D:F.545, D:L.557, D:A.558 Hydrogen bonds: D:W.239, D:F.547, D:F.547 Salt bridges: D:R.212, D:R.212, D:R.243, D:R.486, D:R.550 Metal complexes: D:C.552 HEM.14: 33 residues within 4Å: Chain E: R.212, V.231, F.232, W.239, R.243, L.306, E.412, L.413, G.416, S.417, T.420, T.421, P.424, L.475, V.480, G.481, F.483, L.484, R.486, P.544, F.545, G.546, F.547, M.549, R.550, Q.551, C.552, L.553, G.554, L.557, A.558, M.562 Ligands: 0T3.15 19 PLIP interactions: 19 interactions with chain E, Hydrophobic interactions: E:V.231, E:F.232, E:L.413, E:P.424, E:L.475, E:V.480, E:L.484, E:F.545, E:L.557, E:A.558 Hydrogen bonds: E:W.239, E:F.547, E:F.547 Salt bridges: E:R.212, E:R.212, E:R.243, E:R.486, E:R.550 Metal complexes: E:C.552 HEM.17: 33 residues within 4Å: Chain F: R.212, V.231, F.232, W.239, R.243, L.306, E.412, L.413, G.416, S.417, T.420, T.421, P.424, L.475, V.480, G.481, F.483, L.484, E.485, R.486, P.544, F.545, G.546, F.547, R.550, Q.551, C.552, L.553, G.554, L.557, A.558, M.562 Ligands: 0T3.18 18 PLIP interactions: 18 interactions with chain F, Hydrophobic interactions: F:V.231, F:F.232, F:L.413, F:P.424, F:L.484, F:F.545, F:L.553, F:L.557, F:A.558 Hydrogen bonds: F:W.239, F:F.547, F:F.547 Salt bridges: F:R.212, F:R.212, F:R.243, F:R.486, F:R.550 Metal complexes: F:C.552

6 x 0T3: 4-[(5R)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl]benzonitrile(Non-covalent)

0T3.3: 13 residues within 4Å: Chain A: W.218, R.222, F.232, M.332, F.333, W.362, E.412, A.415, G.416, T.420, F.589, I.590 Ligands: HEM.2 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.218, A:F.333, A:A.415, A:T.420, A:F.589, A:I.590 Hydrogen bonds: A:R.222 pi-Stacking: A:F.232, A:F.232 0T3.6: 13 residues within 4Å: Chain B: W.218, R.222, F.232, M.332, F.333, W.362, E.412, A.415, G.416, T.420, F.589, I.590 Ligands: HEM.5 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:W.218, B:F.232, B:F.333, B:A.415, B:T.420, B:F.589 Hydrogen bonds: B:R.222 pi-Stacking: B:W.218, B:F.232 0T3.9: 13 residues within 4Å: Chain C: W.218, R.222, F.232, M.332, F.333, W.362, E.412, A.415, G.416, T.420, F.589, I.590 Ligands: HEM.8 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:W.218, C:F.232, C:F.333, C:A.415, C:T.420, C:F.589, C:I.590 Hydrogen bonds: C:R.222 pi-Stacking: C:F.232, C:F.232 0T3.12: 13 residues within 4Å: Chain D: W.218, R.222, F.232, M.332, F.333, W.362, E.412, A.415, G.416, T.420, F.589, I.590 Ligands: HEM.11 9 PLIP interactions: 9 interactions with chain D Hydrophobic interactions: D:W.218, D:F.333, D:A.415, D:T.420, D:F.589, D:I.590 Hydrogen bonds: D:R.222 pi-Stacking: D:F.232, D:F.232 0T3.15: 13 residues within 4Å: Chain E: W.218, R.222, F.232, M.332, F.333, W.362, E.412, A.415, G.416, T.420, F.589, I.590 Ligands: HEM.14 9 PLIP interactions: 9 interactions with chain E Hydrophobic interactions: E:W.218, E:F.232, E:F.333, E:A.415, E:T.420, E:F.589 Hydrogen bonds: E:R.222 pi-Stacking: E:W.218, E:F.232 0T3.18: 13 residues within 4Å: Chain F: W.218, R.222, F.232, M.332, F.333, W.362, E.412, A.415, G.416, T.420, F.589, I.590 Ligands: HEM.17 10 PLIP interactions: 10 interactions with chain F Hydrophobic interactions: F:W.218, F:F.232, F:F.333, F:A.415, F:T.420, F:F.589, F:I.590 Hydrogen bonds: F:R.222 pi-Stacking: F:F.232, F:F.232

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brixius-Anderko, S. et al., Structural and functional insights into aldosterone synthase interaction with its redox partner protein adrenodoxin. J.Biol.Chem. (2021)

Release Date

2021-05-26

Peptides

Adrenodoxin, Cytochrome P450 11B2, mitochondrial fusion enzyme: ABCDEF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
A

E
B

F
C

Adrenodoxin, Cytochrome P450 11B2, mitochondrial fusion enzyme